International regulatory issues for innovative medicines
- At: 2006 FIP Congress in Salvadore (Brazil)
- Type: Presentation
- By: JUILLET, Yves (Leem, General Management, Paris Cedex 16, France)
The aim of harmonisation of regulatory requirements for registration is to allow patients quicker access to new drugs , to avoid animal and human trials duplication but also guaranteeing at the same time public health and patient safety. Harmonisation of regulation in the European Union (EU) is now completed, and has led to the submission.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.